Article Versions Notes

Suriya U, Mahalapbutr P, Wimonsong W, Yotphan S, Choowongkomon K, Rungrotmongkol T. Quinoxalinones as A Novel Inhibitor Scaffold for EGFR (L858R/T790M/C797S) Tyrosine Kinase: Molecular Docking, Biological Evaluations, and Computational Insights. Molecules. 2022; 27(24):8901. https://doi.org/10.3390/molecules27248901

Suriya, Utid, Panupong Mahalapbutr, Watchara Wimonsong, Sirilata Yotphan, Kiattawee Choowongkomon, and Thanyada Rungrotmongkol. 2022. "Quinoxalinones as A Novel Inhibitor Scaffold for EGFR (L858R/T790M/C797S) Tyrosine Kinase: Molecular Docking, Biological Evaluations, and Computational Insights" Molecules 27, no. 24: 8901. https://doi.org/10.3390/molecules27248901

Suriya, U., Mahalapbutr, P., Wimonsong, W., Yotphan, S., Choowongkomon, K., & Rungrotmongkol, T. (2022). Quinoxalinones as A Novel Inhibitor Scaffold for EGFR (L858R/T790M/C797S) Tyrosine Kinase: Molecular Docking, Biological Evaluations, and Computational Insights. Molecules, 27(24), 8901. https://doi.org/10.3390/molecules27248901